feed,title,long_url,short_url
Benzinga,Kinnate Biopharma in Focus: Analyst's Adjusted Price Target and the Potential of KIN-3248,https://benzinga.com/general/biotech/23/05/32473008/kinnate-biopharma-in-focus-analysts-adjusted-price-target-and-the-potential-of-kin-3248,https://da.gd/d4TJuR
